Emerging Sample Treatments in Proteomics / Advances in Experimental Medicine and Biology Bd.1073 (PDF)

Name: Emerging Sample Treatments in Proteomics / Advances in Experimental Medicine and Biology Bd.1073
Brand: Springer-Verlag GmbH
SKU: 125338293
Price: 98.99 EUR
Availability: OnlineOnly

(Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Emerging Sample Treatments in Proteomics / Advances in Experimental Medicine and Biology Bd.1073".

Merken

Proteomics is a well-established area of Science; yet with a strong area in constant evolution, namely sample treatment. There few books that currently cover the field of emerging sample treatments in proteomics, this new volume will be the first to cover...

Mehr zum Inhalt Autorenporträt Video

eBook (pdf) 98.99 €

Buch (Gebunden) 109.99 €

sofort als Download lieferbar

Bestellnummer: 125338293

Printausgabe 109.99 €

eBook (pdf) -10% 98.99 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Emerging Sample Treatments in Proteomics / Advances in Experimental Medicine and Biology Bd.1073 (PDF)“

This unique book presents the latest advances in the field focusing on emerging trends linked to high-resolution mass spectrometry, technology addressed to treat samples faster and to attempts to simplify the proteome for the reader.

Autoren-Porträt

Dr. J. L. Capelo is co-head of the bioscopegroup (www.bioscopegroup.org) and his CV comprises (up to December 2018): 224 manuscripts; 205 congress communications (orals and posters); 23 projects; 2 Patents, 1 license agreement and 1 book. He has chaired 39 international conferences and presently is involved in the direction of 7. He was member of the advisory board of Talanta from 2006 to 2014, and he is Editor in Chief of the on-line Journal JIOMICS (www.JIOMICS.com) since its creation in 2011. He is presently mentoring or co-mentoring a total of seven doctoral theses and he has mentored 3 post-doctoral grants, 10 doctoral grants, 9 masters and 8 final projects. His current research interest is devoted to developing new methodological approaches in biomarker discovery using nanoparticles and new proteomics approaches to unravel bacterial resistance to antibiotics. He is Fellow Member of the Royal Society of Chemistry and member of the Portuguese Society of Chemistry.